Non-specific lipid-transfer Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Biological Context

Non-specific lipid-transfer antibodies refer to IgE immunoglobulins produced in response to nsLTPs, which are small (7–9 kDa), cysteine-rich plant proteins stabilized by four disulfide bonds . These antibodies bind to nsLTPs’ conserved structural motifs, including their hydrophobic lipid-binding cavities .

Key features of nsLTPs driving antibody production:

  • Thermal/proteolytic stability: Resistant to digestive enzymes, allowing intact proteins to reach the gut immune system .

  • Lipid-binding plasticity: Their hydrophobic cavities accommodate diverse ligands (e.g., fatty acids, phospholipids), which modulate IgE reactivity .

  • Cross-reactivity: Antibodies against nsLTPs (e.g., Pru p 3 in peach) often recognize homologous proteins in unrelated plants (e.g., apples, walnuts) .

Mechanism of Allergic Sensitization

nsLTP-specific IgE antibodies are generated through a lipid-dependent pathway:

Table 1: Lipid-NsLTP Interactions and Antibody Responses

Lipid TypeEffect on nsLTP StructureImpact on IgE BindingSource
PhytosphingosineStabilizes Pru p 3-lipid complexesEnhances IgE recognition
Palmitic acidExpands hydrophobic cavity volumeIncreases allergenicity
Oleic acidModulates CD1d presentation on APCs*Promotes TH2 polarization

*APCs: Antigen-presenting cells

Lipid-bound nsLTPs activate invariant natural killer T (iNKT) cells via CD1d receptors, promoting TH2 cytokine secretion (e.g., IL-4, IL-13) and IgE production . This adjuvant-like effect explains why lipid-rich foods (e.g., nuts, peaches) are common triggers .

Clinical and Epidemiological Data

Geographic prevalence:

  • Mediterranean regions: 70–80% of food-induced anaphylaxis cases involve nsLTP sensitization .

  • Northern Europe: Low incidence (<10%), potentially due to dietary and environmental differences .

Severity correlation:

  • Higher IgE titers against Pru p 3 correlate with systemic reactions (e.g., urticaria, anaphylaxis) .

  • Lipid content in foods amplifies IgE cross-linking efficiency, worsening symptoms .

Diagnostic Tools

  • Component-resolved diagnostics (CRD): Recombinant nsLTPs (e.g., Pru p 3, Tri a 14) improve allergy testing specificity .

  • In vitro models: THP-1 monocyte activation assays quantify nsLTP immunogenicity .

Therapeutic Strategies

  • Immunotherapy: Sublingual/oral protocols using lipid-free nsLTPs reduce IgE reactivity in trials .

  • Lipid removal: Delipidated nsLTPs show reduced IgE binding, suggesting a path for hypoallergenic vaccines .

Unresolved Questions

  • Why do some individuals develop nsLTP-specific IgE despite ubiquitous exposure?

  • How do lipid variations (e.g., saturated vs. unsaturated) influence antibody affinity?

Future studies must address nsLTP-lipid complexes’ role in dendritic cell priming and epigenetic regulation of IgE synthesis .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
antibody; Non-specific lipid-transfer protein antibody; LTP antibody; Phospholipid transfer protein antibody; PLTP antibody; allergen Zea m 14 antibody
Uniprot No.

Target Background

Function
Plant non-specific lipid-transfer proteins facilitate the transfer of phospholipids and galactolipids across membranes. These proteins potentially play a role in the deposition of wax or cutin within the cell walls of expanding epidermal cells and specific secretory tissues.
Database Links

STRING: 4577.GRMZM2G101958_P01

UniGene: Zm.89638

Protein Families
Plant LTP family

Q&A

What are non-specific lipid-transfer proteins and how do they function in immunological contexts?

Non-specific lipid-transfer proteins (nsLTPs) are small, stable proteins capable of binding and transporting various lipids. They feature a highly conserved three-dimensional structure with four α-helices linked by four disulfide bridges, making them remarkably resistant to heat and pepsin digestion . This structural stability allows nsLTPs to reach the intestinal immune system intact, potentially triggering allergic reactions in sensitive individuals.

In immunological contexts, nsLTPs function as important allergens, particularly in Mediterranean countries where they represent the main cause of primary food allergy in adults . Their ability to bind various lipids contributes significantly to their allergenic properties by potentially altering protein structure, stability, and IgE-binding sites .

How do nsLTPs interact with lipids, and what are the implications for antibody recognition?

The interaction between nsLTPs and lipids is complex and versatile. These proteins contain a hydrophobic cavity that can accommodate various lipid molecules. This interaction is not highly specific – nsLTPs can bind a broad variety of lipids due to the versatile binding abilities of their cavity .

The lipid binding can affect antibody recognition in several ways:

  • Structural modifications: Lipid binding may slightly alter the protein structure, potentially affecting conformational IgE-binding sites

  • Stability changes: Lipid-bound nsLTPs may exhibit different stability profiles, influencing their persistence in various environments

  • Epitope masking or exposure: Lipid binding might mask or expose certain epitopes, altering antibody recognition patterns

When developing antibodies against nsLTPs for research or diagnostic purposes, these lipid-binding considerations are crucial as they may affect specificity and sensitivity of antibody-based detection methods .

What are the primary methodologies used to study nsLTP-antibody interactions?

Researchers employ several complementary methodologies to study nsLTP-antibody interactions:

  • In vitro binding assays: These include enzyme-linked immunosorbent assays (ELISAs), immunoblotting, and surface plasmon resonance (SPR) to quantify and characterize binding kinetics between nsLTPs and specific antibodies.

  • Immunolocalization techniques: As demonstrated with AgLTP24, immunolocalization can identify where nsLTPs are present in tissues. For example, AgLTP24 was localized on deformed root-hair surfaces and bound to the surface of specialized nitrogen-fixing cells .

  • Recombinant protein production: nsLTPs can be biologically produced in heterologous hosts and purified for functional assays, allowing researchers to study native and modified forms .

  • Molecular modeling: In silico experiments use computational approaches to predict interactions between different lipid ligands and nsLTPs, providing insights into how these interactions might affect antibody binding .

These methods collectively provide researchers with tools to understand the complex relationship between nsLTPs, their lipid cargo, and antibody recognition.

How do lipid-nsLTP complexes influence immune responses through CD1d-restricted pathways?

The interaction between nsLTPs and lipids creates complexes that can significantly impact immune responses through CD1d-restricted pathways. Research indicates that these complexes can activate invariant natural killer T (iNKT) cells through a specific mechanism:

  • The nsLTP acts as a carrier protein for lipid cargo such as phytosphingosine

  • The complex is internalized by antigen-presenting cells (APCs)

  • Lipids are loaded onto CD1d molecules within the APCs

  • These CD1d-lipid complexes are presented to iNKT cells (specifically those with Vα24/Jα18+ TCR in humans)

  • Activated iNKT cells may then promote allergic sensitization by inducing TH2-cytokine secretion

Experimental evidence has shown that epicutaneous sensitization with Pru p 3-lipid complexes induced higher levels of Pru p 3-specific IgE antibodies and enhanced basophil activation compared to Pru p 3 alone . Furthermore, the lipid component appears critical, as modification of the phytosphingosine chain can manipulate iNKT cells to produce different amounts of IL-4 or IFN-γ, thereby polarizing immune responses toward either TH1 or TH2 .

This pathway represents an important consideration when developing and using antibodies against nsLTPs, as the presence of bound lipids may significantly alter immunological outcomes in experimental settings.

What are the methodological challenges in isolating and characterizing natural lipid ligands bound to nsLTPs?

Isolating and characterizing natural lipid ligands bound to nsLTPs presents several methodological challenges:

  • Avoiding lipid contamination: The purification of recombinant nsLTPs can be associated with co-purification and binding of lipids from either the natural source or the heterologous expression system used . This makes it difficult to distinguish between naturally bound lipids and experimental contaminants.

  • Discriminating binding locations: Precise analysis is required to determine whether lipids are bound within the cavity of nsLTPs or merely attached to the protein surface .

  • Accounting for pre-loaded lipids: For accurate assessment of lipid binding properties, any natural, pre-loaded lipids need to be excluded or accounted for in the analysis .

  • Considering developmental changes: The composition of lipids and free sterols changes during the development and ripening of plant tissues, adding temporal variability to nsLTP-lipid studies .

  • Reconciling in vitro vs. natural binding: While in vitro experiments show nsLTPs can bind various lipids, studies of natural Pru p 3 have identified a single major lipid ligand, suggesting more selective binding in natural contexts .

These challenges highlight the need for comprehensive analytical approaches when studying nsLTP-antibody interactions in research settings.

How can structural analysis techniques be optimized to study conformational changes in nsLTPs upon lipid binding?

Optimizing structural analysis techniques to study conformational changes in nsLTPs upon lipid binding requires a multi-faceted approach:

  • X-ray crystallography optimization: To capture nsLTP-lipid complexes in their native conformation, researchers should:

    • Experiment with various crystallization conditions that maintain lipid-protein interactions

    • Use microseeding techniques to improve crystal quality

    • Consider lipid-protein co-crystallization versus soaking methods

  • NMR spectroscopy adaptations:

    • Implement 15N-1H heteronuclear single quantum coherence (HSQC) experiments to monitor chemical shift perturbations upon lipid binding

    • Use saturation transfer difference (STD) NMR to identify lipid moieties in direct contact with the protein

    • Apply relaxation dispersion experiments to capture transient structural states during binding

  • Molecular dynamics simulations:

    • Develop specialized force fields that accurately represent lipid-protein interactions

    • Implement enhanced sampling techniques to overcome energy barriers between conformational states

    • Use coarse-grained models to extend simulation timescales for capturing complete binding events

  • Small-angle X-ray scattering (SAXS) adaptations:

    • Optimize buffer conditions to minimize aggregation while maintaining protein-lipid complexes

    • Implement time-resolved SAXS to capture dynamic conformational changes

    • Combine with computational modeling for more accurate structural interpretations

Each of these approaches provides complementary information about structural changes that may affect antibody recognition sites, essential knowledge for researchers developing or using antibodies against nsLTPs .

What factors influence cross-reactivity patterns of nsLTP antibodies across different plant species?

Cross-reactivity patterns of nsLTP antibodies across plant species are influenced by several key factors:

Understanding these factors is crucial when designing experiments using nsLTP antibodies, particularly when studying allergen cross-reactivity or when using antibodies as diagnostic tools across multiple plant species.

How does the experimental design influence the detection of nsLTP-lipid complexes versus unbound nsLTPs?

The experimental design significantly impacts whether nsLTP-lipid complexes or unbound nsLTPs are preferentially detected:

Experimental FactorEffect on Detection of nsLTP-Lipid ComplexesEffect on Detection of Unbound nsLTPs
Sample preparation methodsHarsh detergents may disrupt lipid-protein interactionsGentle extraction preserves native state
Buffer compositionHigh salt concentrations may disrupt electrostatic interactions between lipids and proteinsPhysiological buffers maintain native interactions
Temperature conditionsHigher temperatures may destabilize lipid-protein complexesCold conditions preserve complexes but may alter protein conformation
Antibody selectionConformation-specific antibodies may only recognize the complex or free formPan-reactive antibodies detect both forms but provide less structural information
Detection platformNative PAGE preserves complexes but has lower resolutionSDS-PAGE disrupts complexes but provides better protein separation

Researchers should carefully consider these factors when designing experiments to study nsLTP antibody interactions, especially when the goal is to understand the effect of lipid binding on antibody recognition . The experimental design might need to be adjusted depending on whether the research question focuses on the lipid-bound or unbound state of the nsLTP.

What methodological approaches can distinguish between natural nsLTP antibodies and those produced for research purposes?

Distinguishing between natural nsLTP antibodies (such as those produced during allergic responses) and laboratory-produced research antibodies requires specific methodological approaches:

  • Epitope mapping analysis:

    • Natural IgE antibodies from allergic patients often recognize specific conformational epitopes

    • Research antibodies can be characterized by epitope mapping techniques including peptide arrays and hydrogen-deuterium exchange mass spectrometry

    • Comparative epitope analysis can reveal differences in binding sites between natural and research antibodies

  • Isotype and subclass characterization:

    • Natural nsLTP responses often involve IgE in allergic patients and other isotypes in non-allergic individuals

    • Research antibodies can be specifically engineered with defined isotypes (IgG, IgM, etc.)

    • Isotype-specific secondary antibodies can be used to discriminate between them in experimental settings

  • Affinity and avidity measurements:

    • Natural antibodies often display polyclonal heterogeneity with variable affinities

    • Research antibodies, especially monoclonals, have defined affinity characteristics

    • Surface plasmon resonance with kinetic analysis can differentiate between these populations

  • Cross-reactivity profiling:

    • Natural antibodies may show broader cross-reactivity patterns aligned with clinical allergy profiles

    • Research antibodies can be selected for specific cross-reactivity properties

    • Protein microarrays with multiple nsLTPs can generate comprehensive cross-reactivity profiles

These approaches allow researchers to understand differences between natural immune responses to nsLTPs and the binding properties of research-grade antibodies, which is critical for interpreting experimental results correctly .

How can nsLTP antibodies be utilized to study plant-microbe interactions in symbiotic relationships?

nsLTP antibodies serve as valuable tools for investigating plant-microbe symbiotic relationships, as demonstrated by research on AgLTP24:

  • Spatial localization studies: Immunolocalization using nsLTP antibodies can precisely identify where these proteins function during microbial interactions. In the case of AgLTP24, antibodies revealed its presence on deformed root-hair surfaces—critical contact points for Frankia bacteria during infection—and later on the surface of specialized nitrogen-fixing vesicles .

  • Temporal expression analysis: By combining antibody-based detection with time-course sampling, researchers can track the changing distribution and abundance of nsLTPs throughout symbiotic development, from initial infection to mature nodule formation .

  • Functional blocking experiments: Antibodies can be used to selectively block nsLTP function in living systems, helping determine whether these proteins are essential for successful symbiotic establishment or maintenance.

  • Protein-protein interaction studies: Immunoprecipitation with nsLTP antibodies can identify binding partners during different stages of symbiotic interactions, revealing molecular mechanisms.

  • Purification for functional analysis: Antibodies facilitate the isolation of native nsLTPs from plant tissues for subsequent functional assays, as demonstrated when AgLTP24 was purified to study its effects on Frankia alni ACN14a .

These applications demonstrate how nsLTP antibodies extend beyond simple detection to enable sophisticated investigation of complex biological processes in plant-microbe symbioses.

What techniques can resolve contradictory findings about nsLTP structural changes upon lipid binding?

Resolving contradictory findings about nsLTP structural changes upon lipid binding requires integrated analytical approaches:

  • Time-resolved structural analysis:

    • Implementing stopped-flow techniques with synchrotron radiation circular dichroism to capture rapid structural transitions

    • Using time-resolved small-angle X-ray scattering to monitor conformational dynamics during lipid binding

    • These approaches can identify transient states missed by equilibrium measurements

  • Single-molecule techniques:

    • Förster resonance energy transfer (FRET) with strategically placed fluorophores to detect subtle conformational changes

    • Atomic force microscopy to directly visualize structural variations in individual nsLTP molecules

    • These methods overcome limitations of ensemble averaging that might mask heterogeneous behaviors

  • Computational validation strategies:

    • Molecular dynamics simulations with enhanced sampling to generate testable hypotheses about conformational changes

    • Metadynamics approaches to calculate free energy landscapes of protein-lipid interactions

    • These computational predictions can guide targeted experimental validation

  • Controlled lipid delivery systems:

    • Developing lipid nanodisc technologies to present lipids in more physiologically relevant contexts

    • Using microfluidic approaches for precise temporal control of lipid exposure

    • These systems provide more consistent experimental conditions for resolving contradictory findings

The current controversy regarding whether lipid binding induces significant structural flexibility in the binding cavity of nsLTPs could be resolved using these approaches, providing clearer understanding of how antibody epitopes might be affected by lipid binding .

How do experimental conditions influence the immunomodulatory properties of nsLTP-lipid complexes?

Experimental conditions significantly impact the immunomodulatory properties of nsLTP-lipid complexes, with important implications for antibody development and immunological research:

Experimental ConditionImpact on Immunomodulatory PropertiesResearch Considerations
pH variationsAlters lipid binding capacity and stability of nsLTP-lipid complexesBuffer systems should mimic physiological compartments (e.g., gastric pH vs. intestinal pH)
TemperatureAffects conformation and stability of complexesResearch conducted at non-physiological temperatures may not reflect in vivo activity
Lipid compositionDifferent lipids induce varying cytokine profilesPhytosphingosine modifications can manipulate iNKT cells to produce different ratios of IL-4/IFN-γ
Presence of cofactorsNSAIDs and exercise can exacerbate nsLTP-mediated reactionsExperimental design should account for relevant cofactors
Concentration ratiosLipid:protein ratios affect complex formation and stabilityTitration experiments should be performed to determine optimal ratios
Delivery methodRoute of administration affects immunological outcomeConsider differences between topical, oral, and injected administration

What emerging technologies show promise for advancing nsLTP antibody research?

Several emerging technologies show significant promise for advancing nsLTP antibody research:

  • Single-cell antibody sequencing technologies:

    • Allow identification of rare nsLTP-specific B cell clones from allergic patients

    • Enable comparison of antibody repertoires between different patient populations

    • Facilitate the development of more specific diagnostic antibodies

  • CRISPR-based protein engineering:

    • Enables precise modification of nsLTP structures to study epitope-antibody interactions

    • Facilitates the creation of modified nsLTPs with altered lipid-binding properties

    • Supports the development of hypoallergenic variants for immunotherapy research

  • Advanced imaging technologies:

    • Super-resolution microscopy for visualizing nsLTP-antibody interactions at nanoscale

    • Cryo-electron microscopy for capturing antibody binding to nsLTP-lipid complexes

    • Correlative light and electron microscopy for tracking nsLTPs in complex biological environments

  • Artificial intelligence applications:

    • Machine learning algorithms for predicting cross-reactivity patterns across plant species

    • Deep learning approaches for modeling antibody-epitope interactions

    • AI-assisted epitope mapping for more efficient antibody development

  • Organ-on-chip technologies:

    • Microfluidic systems that model epithelial barriers for studying nsLTP transport

    • Integrated immune components to investigate tissue-specific antibody responses

    • Controlled microenvironments for studying cofactor effects on nsLTP-antibody interactions

These technologies will enable more precise characterization of nsLTP-antibody interactions and advance our understanding of the immunological mechanisms underlying nsLTP-mediated allergies and plant-microbe interactions .

How can methodological standardization improve comparability across nsLTP antibody research?

Methodological standardization would significantly enhance comparability across nsLTP antibody research through several key approaches:

  • Standardized antibody characterization protocols:

    • Establishing minimum reporting requirements for antibody specificity testing

    • Developing reference panels of well-characterized nsLTPs from different plant sources

    • Creating standard protocols for cross-reactivity assessment across plant species

  • Consistent lipid binding assessment methods:

    • Standardizing lipid extraction and analysis protocols to ensure comparability

    • Establishing reference lipid mixtures that mimic physiologically relevant conditions

    • Developing consensus methods for discriminating between cavity-bound and surface-attached lipids

  • Unified structural analysis approaches:

    • Implementing standardized conditions for analyzing nsLTP conformational changes

    • Creating shared databases of structural information with raw data availability

    • Developing benchmark datasets for validating computational predictions

  • Harmonized immunoassay procedures:

    • Establishing calibrated reference materials for quantitative antibody measurements

    • Standardizing sample preparation to preserve native nsLTP-lipid complexes

    • Creating consensus protocols for separating bound versus unbound forms

  • Integrated data reporting frameworks:

    • Developing comprehensive metadata standards for experimental conditions

    • Creating centralized repositories for nsLTP antibody research data

    • Establishing ontologies for consistent description of nsLTP-antibody interactions

These standardization efforts would address current challenges in the field, where differences in experimental approaches make it difficult to reconcile findings across studies, particularly regarding the structural changes and immunological impacts of lipid binding to nsLTPs .

What are the key methodological considerations for researchers new to nsLTP antibody studies?

Researchers entering the field of nsLTP antibody studies should consider several critical methodological aspects:

  • Sample preparation considerations:

    • Carefully select extraction methods that preserve native nsLTP-lipid complexes

    • Consider how purification approaches might strip natural lipid ligands

    • Implement controls to account for potential lipid contamination from expression systems

  • Antibody selection guidance:

    • Choose antibodies based on whether conformational or linear epitopes are of interest

    • Consider cross-reactivity profiles when studying multiple plant species

    • Determine whether lipid-bound or unbound forms should be recognized

  • Experimental design principles:

    • Include appropriate controls for lipid-binding effects

    • Consider the influence of physiological cofactors like NSAIDs or exercise that may modify reactions

    • Account for potential protective factors like co-sensitization to PR10 and Profilin

  • Analytical method selection:

    • Match methods to research questions (structural, functional, or immunological)

    • Combine multiple complementary techniques for comprehensive characterization

    • Consider time-resolved approaches to capture dynamic binding events

  • Interpretation frameworks:

    • Recognize the hierarchical nature of nsLTP sensitization

    • Consider both allergenic and non-allergenic contexts for nsLTP function

    • Interpret findings in light of known symbiotic and defensive roles of nsLTPs

By carefully addressing these methodological considerations, new researchers can design more robust studies and contribute meaningfully to this complex and evolving field.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.